XML 51 R40.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes (Details 1) - USD ($)
Dec. 31, 2015
Dec. 31, 2014
Components of Deferred Tax Assets [Abstract]    
Net operating loss carry forwards $ 31,216,000 $ 29,594,000
Orphan drug and research and development credit carry forwards 4,909,000 3,556,000
Equity based compensation 1,923,000 2,049,000
Intangibles 2,090,000 2,140,000
Total 40,138,000 37,339,000
Valuation allowance $ (40,138,000) $ (37,339,000)
Net deferred tax assets